INMB logo

INmune Bio, Inc.

INMB
Healthcare|Biotechnology|US
$1.13
-0.04 (-3.83%)
DCF Value
$0.76
Tangible Book / Share
$0.65
Cash / Share
$0.59
Next Earnings Report
Mar 4, 2027
EPS est. -$0.19 · Revenue est. $1.9M
Financing Filings (last 12 months)
2
Shelf registrations / offering prospectuses — latest Oct 29, 2026 (424B5). Possible dilution.

Upcoming Data Readouts (0)

No upcoming completion dates found in active trials.

Recent Press Releases

INmune Bio Inc. Announces Third Quarter 2026 Results and Provides Business Update
Nov 5, 2026 · GlobeNewsWire
INmune Bio Inc. to Report Third Quarter 2026 Financial Results and Provide Corporate Update on Thursday, November 5th
Oct 29, 2026 · GlobeNewsWire
INmune Bio, Inc. Announces Pricing of $4.50 Million Registered Direct Offering and Concurrent Private Placement
Oct 28, 2026 · GlobeNewsWire
INmune Bio Advances Ebstrocel™ Toward Potential UK Approval in Mid-2027
Oct 21, 2026 · GlobeNewsWire
INmune Bio Establishes Global Commercialization Framework for Ebstrocel™ Through Strategic Agreement with Uniphar
Oct 21, 2026 · GlobeNewsWire
INmune Bio Inc. and Quantum Computing Inc. Partner to Apply Quantum Optimization and AI to Advance Alzheimer's Drug Research and Explore New Applications for XPro ™
Oct 14, 2026 · PRNewsWire
INmune Bio to Attend the 2026 Maxim Growth Summit
Oct 6, 2026 · GlobeNewsWire
INmune Bio Appoints Sanofi Rare-Disease Executive and Biopharma Business Development Leader to Board
Sep 14, 2026 · GlobeNewsWire
INmune Bio to Present at the H.C. Wainwright Global Investment Conference
Sep 9, 2026 · GlobeNewsWire
INmune Bio Advances Ebstrocel™ Toward European Marketing Authorization with EMA Regulatory Filings
Aug 26, 2026 · GlobeNewsWire

SEC Filings (81)

Last two years from EDGAR. Insider Form 4s are on the Ownership tab.

FiledFormWhat it isLinks
Nov 5, 202610-QQuarterly reportDocumentIndex
Oct 29, 20268-KMaterial eventDocumentIndex
Oct 29, 2026424B5Offering prospectusDocumentIndex
Oct 21, 20268-KMaterial eventDocumentIndex
Sep 14, 20268-KMaterial eventDocumentIndex
Aug 6, 202610-QQuarterly reportDocumentIndex
Jul 31, 20268-KMaterial eventDocumentIndex
Jul 1, 20268-KMaterial eventDocumentIndex
Jun 23, 20268-KMaterial eventDocumentIndex
Jun 17, 20268-KMaterial eventDocumentIndex
Jun 2, 20268-KMaterial eventDocumentIndex
May 14, 20268-KMaterial eventDocumentIndex
May 7, 202610-QQuarterly reportDocumentIndex
May 5, 20268-KMaterial eventDocumentIndex
Apr 23, 2026DEF 14AProxy / shareholder voteDocumentIndex
Mar 30, 202610-KAnnual reportDocumentIndex
Feb 27, 20268-KMaterial eventDocumentIndex
Feb 23, 20268-KMaterial eventDocumentIndex
Feb 19, 20268-KMaterial eventDocumentIndex
Feb 13, 20268-KMaterial eventDocumentIndex
Jan 27, 20268-KMaterial eventDocumentIndex
Dec 23, 20258-KMaterial eventDocumentIndex
Dec 19, 20258-KMaterial eventDocumentIndex
Dec 19, 2025424B5Offering prospectusDocumentIndex
Dec 10, 20258-KMaterial eventDocumentIndex
Dec 8, 20258-A12B/ADocumentIndex
Dec 8, 20258-KMaterial eventDocumentIndex
Dec 5, 20258-KMaterial eventDocumentIndex
Dec 3, 20258-KMaterial eventDocumentIndex
Nov 28, 20258-KMaterial eventDocumentIndex
Nov 18, 20258-KMaterial eventDocumentIndex
Nov 10, 20258-KMaterial eventDocumentIndex
Oct 30, 20258-KMaterial eventDocumentIndex
Oct 30, 202510-QQuarterly reportDocumentIndex
Oct 28, 20258-KMaterial eventDocumentIndex
Oct 14, 2025DEF 14AProxy / shareholder voteDocumentIndex
Oct 14, 20258-KMaterial eventDocumentIndex
Oct 3, 2025PRE 14AProxy / shareholder voteDocumentIndex
Sep 30, 20258-KMaterial eventDocumentIndex
Aug 14, 2025SC 13G/APassive 5%+ stakeDocumentIndex